The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $88.99

Today's change-0.56 -0.63%
Updated September 30 4:04 PM EDT. Delayed by at least 15 minutes.
 

CVS Health Corp

NYSE: CVS
Last

(U.S.) $88.99

Today's change-0.56 -0.63%
Updated September 30 4:04 PM EDT. Delayed by at least 15 minutes.

CVS Health Corp down (U.S.)$0.56

CVS Health Corp closed lower Friday, dropping (U.S.)$0.56 or 0.63% to (U.S.)$88.99. Over the last five days, shares have lost 1.78% and sit 2.88% above their 52-week low. This security has underperformed the S&P 500 by 20.69% during the last year.

Key company metrics

  • Open(U.S.) $89.48
  • Previous close(U.S.) $89.55
  • High(U.S.) $89.91
  • Low(U.S.) $88.46
  • Bid / Ask-- / --
  • YTD % change-8.98%
  • Volume9,151,656
  • Average volume (10-day)5,898,731
  • Average volume (1-month)5,348,278
  • Average volume (3-month)5,178,569
  • 52-week range(U.S.) $86.50 to (U.S.) $106.67
  • Beta0.83
  • Trailing P/E20.48×
  • P/E 1 year forward15.29×
  • Forward PEG1.05×
  • Indicated annual dividend(U.S.) $1.70
  • Dividend yield1.91%
  • Trailing EPS(U.S.) $4.35
Updated September 30 4:04 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.19%Sector:Non-Cyclical Consumer Goods & ServicesIndustry:Retail - Drugs
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue43,72543,21541,14638,644
Total other revenue--------
Total revenue43,72543,21541,14638,644
Gross profit7,0156,7447,3016,661
Total cost of revenue36,71036,47133,84531,983
Total operating expense41,91741,03938,41736,313
Selling / general / administrative4,6654,5684,5724,330
Research & development--------
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)542--00
Other operating expenses, total--------
Operating income1,8082,1762,7292,331
Interest income (expense), net non-operating-284-288-282-268
Gain (loss) on sale of assets--------
Other--------
Income before tax1,5281,8932,4532,070
Income after tax9241,1471,5001,237
Income tax, total604746953833
Net income9241,1461,4981,246
Total adjustments to net income-4-6----
Net income before extra. items9241,1461,4991,236
Minority interest0-1-1-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9201,1401,4991,236
Inc. avail. to common incl. extra. items9201,1401,4981,246
Diluted net income9241,1401,4981,246
Dilution adjustment4------
Diluted weighted average shares1,0751,0991,1141,121
Diluted EPS excluding extraordinary itemsvalue per share0.861.041.351.10
Dividends per sharevalue per share0.430.430.350.35
Diluted normalized EPSvalue per share1.161.041.351.10